The Clinical Significance of Plasma Fibronectin, Urinary Fibronectin and Urinary Transferrin in Type 2 Diabetics

秦日文,田浩明,梁荩忠
DOI: https://doi.org/10.3969/j.issn.1672-173X.2002.03.029
2002-01-01
Abstract:Objective To investigate the change of plasma fibronectin (PFn), urinary fibronectin (UFn) and urinary transferrin (UTrf) in the type 2 diabetic patients with nephropathy (DN) and retinopathy (DR). Methods The levels of PFn, UFn, UTrf, urinary albumin exertion rate (AER), urinary β 2-microglubulin (Uβ 2-MG) and urinaryα 1-microglubulin(Uα 1-MG) were measured in 62 type 2 diabetic patients (including 38 DN and 14 DR) and 15 healthy controls. Results No significant changes of PFn were found in type 2 diabetic patients when they were compared with normal controls (P>0. 05). The PFn levels of diabetics with nephropathy and retinopathy were higher than those of diabetics without nephropathy (DWN) and retinopathy (DWR) respectively, but there was no statistical significance (P>0. 05). The excretion of UFn increased significantly in diabetics with nephropathy (P<0. 01), but no significant change of UFn was found in diabetics with retinopathy(P>0. 05). The level of UTrf elevated significantly in diabetics with nephropathy and retinopathy also (P<0. 01). There was no relationship between PFn and UFn, UTrf, AER, Uβ 2-MG, Uα 1-MG, but there was positive relationship between UFn and UTrf, AER, Uβ 2-MG, Uα 1-MG. Conclusion High levels of UFn and UTrf can reflect diabetic nephropathy early. Increased UTrf may reflect diabetic retinopathy.
What problem does this paper attempt to address?